339 related articles for article (PubMed ID: 30053879)
1. Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter.
Redmer T
Mol Cancer; 2018 Jul; 17(1):106. PubMed ID: 30053879
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.
Harding JJ; Catalanotti F; Munhoz RR; Cheng DT; Yaqubie A; Kelly N; McDermott GC; Kersellius R; Merghoub T; Lacouture ME; Carvajal RD; Panageas KS; Berger MF; Rosen N; Solit DB; Chapman PB
Oncologist; 2015 Jul; 20(7):789-97. PubMed ID: 25956405
[TBL] [Abstract][Full Text] [Related]
3. PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.
Niessner H; Schmitz J; Tabatabai G; Schmid AM; Calaminus C; Sinnberg T; Weide B; Eigentler TK; Garbe C; Schittek B; Quintanilla-Fend L; Bender B; Mai M; Praetorius C; Beissert S; Schackert G; Muders MH; Meinhardt M; Baretton GB; Dummer R; Flaherty K; Pichler BJ; Kulms D; Westphal D; Meier F
Clin Cancer Res; 2016 Dec; 22(23):5818-5828. PubMed ID: 27307593
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain.
Guo R; Fierro-Fine A; Goddard L; Russell M; Chen J; Liu CZ; Fung KM; Hassell LA
Int J Clin Exp Pathol; 2014; 7(12):8947-51. PubMed ID: 25674270
[TBL] [Abstract][Full Text] [Related]
5. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
7. CD271 determines migratory properties of melanoma cells.
Radke J; Roßner F; Redmer T
Sci Rep; 2017 Aug; 7(1):9834. PubMed ID: 28852061
[TBL] [Abstract][Full Text] [Related]
8. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
[TBL] [Abstract][Full Text] [Related]
9. Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas.
Dankner M; Lajoie M; Moldoveanu D; Nguyen TT; Savage P; Rajkumar S; Huang X; Lvova M; Protopopov A; Vuzman D; Hogg D; Park M; Guiot MC; Petrecca K; Mihalcioiu C; Watson IR; Siegel PM; Rose AAN
Clin Cancer Res; 2018 Dec; 24(24):6483-6494. PubMed ID: 29903896
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
11. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
[TBL] [Abstract][Full Text] [Related]
12. PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
Jilaveanu LB; Parisi F; Barr ML; Zito CR; Cruz-Munoz W; Kerbel RS; Rimm DL; Bosenberg MW; Halaban R; Kluger Y; Kluger HM
Clin Cancer Res; 2015 May; 21(9):2138-47. PubMed ID: 25316811
[TBL] [Abstract][Full Text] [Related]
13. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
[TBL] [Abstract][Full Text] [Related]
14. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.
Sperduto PW; Jiang W; Brown PD; Braunstein S; Sneed P; Wattson DA; Shih HA; Bangdiwala A; Shanley R; Lockney NA; Beal K; Lou E; Amatruda T; Sperduto WA; Kirkpatrick JP; Yeh N; Gaspar LE; Molitoris JK; Masucci L; Roberge D; Yu J; Chiang V; Mehta M
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1069-1077. PubMed ID: 28721890
[TBL] [Abstract][Full Text] [Related]
16. Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies.
Gibney GT; Zager JS
Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):893-9. PubMed ID: 23621583
[TBL] [Abstract][Full Text] [Related]
17. CCR4 is a determinant of melanoma brain metastasis.
Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into melanoma brain metastases.
Westphal D; Glitza Oliva IC; Niessner H
Cancer; 2017 Jun; 123(S11):2163-2175. PubMed ID: 28543697
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
20. SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
Hüser L; Sachindra S; Granados K; Federico A; Larribère L; Novak D; Umansky V; Altevogt P; Utikal J
Int J Cancer; 2018 Dec; 143(12):3131-3142. PubMed ID: 29905375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
